NAYA Biosciences
NAYA Biosciences announced a strategic decision to separate its fertility and oncology businesses into distinct operations. The website includes an accessibility policy referencing WCAG 2.1 Level A and AA guidelines and provides contact information for accessibility inquiries.
Industries
biotechnology
health-care
Nr. of Employees
small (1-50)
NAYA Biosciences
Products
Multifunctional Antibody Platform
A platform for designing and developing multifunctional antibodies targeting cancer and autoimmune diseases.
GPC3-targeted NK Engager Bispecific Antibody
A bispecific antibody designed to engage natural killer cells targeting GPC3-expressing hepatocellular carcinoma cells.
Fertility Treatment Services (INVOcell)
Fertility treatment services utilizing the INVOcell device for intravaginal embryo incubation.
Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)
A gene therapy program targeting LHON, a mitochondrial genetic disorder causing vision loss.
Multifunctional Antibody Platform
A platform for designing and developing multifunctional antibodies targeting cancer and autoimmune diseases.
GPC3-targeted NK Engager Bispecific Antibody
A bispecific antibody designed to engage natural killer cells targeting GPC3-expressing hepatocellular carcinoma cells.
Fertility Treatment Services (INVOcell)
Fertility treatment services utilizing the INVOcell device for intravaginal embryo incubation.
Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)
A gene therapy program targeting LHON, a mitochondrial genetic disorder causing vision loss.
Expertise Areas
- Fertility
- Oncology
- Web accessibility compliance
Key Technologies
- Web accessibility standards (WCAG 2.1 Level A/AA)